447 related articles for article (PubMed ID: 17408459)
1. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
4. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
[TBL] [Abstract][Full Text] [Related]
5. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
7. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
8. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
9. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
Zhang JQ; Wang JK; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
[TBL] [Abstract][Full Text] [Related]
10. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
[TBL] [Abstract][Full Text] [Related]
12. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
13. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
14. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
[TBL] [Abstract][Full Text] [Related]
17. Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma.
Donckier JE; Michel L; Delos M; Havaux X; Van Beneden R
Clin Endocrinol (Oxf); 2006 Jun; 64(6):703-10. PubMed ID: 16712675
[TBL] [Abstract][Full Text] [Related]
18. Shwachman-Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis.
Leung EW; Rujkijyanont P; Beyene J; Wei K; Abdelhaleem M; Freedman MH; Dror Y
Br J Haematol; 2006 Jun; 133(5):558-61. PubMed ID: 16681645
[TBL] [Abstract][Full Text] [Related]
19. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
